Therapeutic evaluation and efficacy of Regimenal modality (Dry Cupping)and Unani formulation (Asbi drug) in the management of Diabetic peripheral Neuropathy

Therapeutic evaluation and efficacy of ?ij ?ma bil ? sh ?rt and Asbi Un ?ni formulation in the management of Diabetic Peripheral Neuropathy - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/065099

Enrollment

Registered

2024-04-02

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications

Interventions

Intervention1: Asbi drug hijama bila shart: In this group patients will be treated with Hijama Bila Shart (Dry cupping) for 10 minutes in every alternative days for 30 days. along with patient will b

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient with diabetes mellitus type 1 and type 2.stable blood glucose level less than 200mg/dl. that is HBsAg less than 9% 3. patients complain of pain in foot, burning and tingling sensation

Exclusion criteria

Exclusion criteria: 1. patients less than 25 years and above 60 years 2.Pregnant and lactating women 3.History of malignancy and tumour. 4.Other causes of neuropathy 5.Any spinal diseases 6.Skin lesions or skin allergy

Design outcomes

Primary

Measure	Time frame
Machigan neuropathy instrument Vibration perception thresholdTimepoint: 0 day and 30th day	—

Secondary

Measure	Time frame
Pain in feet tingling and burning sensationTimepoint: every alternative days,for one month	—

Countries

India

Contacts

Public ContactSimran Khan

Hakim Syed Ziaul Hasan Government/Autonomous Unani Medical College and Hospital Bhopal, (M.P.)

arifanees110@gmail.com7354297787

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026